ABSTRACT
@#Human infection with the novel coronavirus (COVID-19) has provoked public health concerns over sexual health. The novel coronavirus is a serious threat to public health. Evidence suggests that one of the major concerns of couples is sexual intercourse during the novel coronavirus pandemic. Detection of sexual challenge in novel coronavirus pandemic, as one of the risk factors, can promote sexual health. Knowledge about the new coronavirus is limited; little information is available about COVID-19 and sex life during the pandemic. In this review, we summarized the latest research and related reports of the new coronavirus and sex lives and discussed them to protect the sexual health in order to combat COVID-19. To this end, strategies have been proposed to increase sexual health and reduce sexual challenges so that we can avoid the harmful outcome of this virus. We hope that following and applying the sexual health guidelines will be able to overcome this difficulty with the least physical, mental, and social harm. Furthermore, special attention is expected from responsible authorities or public health officials to develop strategic planning for promoting sexual health and improving family relationships during the pandemic of coronavirus.
ABSTRACT
Background: Fertility loss is considered as a challenging experience. This study was conducted to compare the effectiveness of antidepressant medication and psychological intervention on depression symptoms in women with infertility and sexual dysfunctions [SD]
Materials and Methods: This randomized, controlled clinical trial study was completed from December 2014 to June 2015 in Babol, Iran. Of the 485 participants, 93 were randomly assigned in a 1: 1: 1 ratio to psychosexual therapy [PST], bupropion extended-release [BUP ER] at a dose of 150 mg/d, and control [no intervention] groups. The Beck Depression Inventory [BDI] was completed at the beginning and end of the study. Duration of study was eight weeks. Statistical analyses were performed by using paired-test and analysis of covariance
Results: The mean depression score on the BDI was 22.35 +/- 8.70 in all participants. Mean BDI score decreased significantly in both treatment groups [PST: P<0.0001, BUP: P<0.002] from baseline to end of the study, whereas intra-individual changes in BDI score were not significant in the control group. The decrease in mean BDI score was greater with PST compared to BUP treatment [P<0.005] and the control group [P<0.0001]. The PST group showed greater improvement in depression levels [severe to moderate, moderate to mild] in comparison with the two other groups [P<0.001]. Drug treatment was well tolerated by the participants in the BUP group
Conclusion: PST can be a reliable alternative to BUP ER for relieving depression symptoms in an Iranian population of women with infertility and SD
ABSTRACT
Background: The use of assisted reproductive technology [ART] is increasing in the world. The rate, efficacy and safety of ART are very different among countries. There is an increase in the use of intra cytoplasmic sperm injection [ICSI], single fresh embryo transfer [ET] and frozen-thawed embryo transfer [FET]
Objective: The objective of this study was to compare pregnancy rate in fresh ET and FET
Materials and Methods: In this retrospective cross-sectional study 1014 ICSI-ET cycles [426 fresh ET and 588 FET] from 753 women undergoing ICSI treatment referred to Fatemezahra Infertility and Reproductive Health Research Center in Babol, Iran from 2008 to 2013 were reviewed
Results: There were no significant differences between biochemical pregnancy rate [23% versus 18.8%, OR 1.301; 95% CI .95-1.774], gestational sac [95.6% versus 100% in FET, OR 0.60; 95% CI 0.54-0.67], and fetal heart activity [87.2% versus 93.6% OR .46; 95% CI .16-1.32] in fresh ET and FET cycles, respectively. P< 0.05 was considered statistically significant for all measures
Conclusion: Although, the result showed no significantly difference between the fresh ET and the FET cycles, however the embryos are able to be stored for subsequent ART. Therefore, we recommend FET cycles as an option alongside the fresh ET
ABSTRACT
The infertility is associated with psychological consequence including depression, and lack of self-efficacy. The aim of this study was to compare the pharmacological and no pharmacological strategies in promotion of self-efficacy of infertile women. A randomized controlled clinical trial was conducted on 89 infertile women who were recruited from Fatemeh Zahra Infertility and Reproductive Health Research Center and were randomized into three groups; cognitive behavioral therapy [CBT], antidepressant therapy with flouxetine 20 mg daily for 3 month, and a control group. All participants completed Infertility Self-efficacy Inventory [ISE] and the Beck Depression Inventory [BDI] at the beginning and end of the study. The means ISE scores among the CBT, fluoxetine, and control groups at the beginning and end of the study were 6.1 +/- 1.6 vs. 7.2 +/- 0.9, 6.4 +/- 1.4 vs. 6.9 +/- 1.3 and 6.1 +/- 1.1 vs. 5.9 +/- 1.4 respectively. Both CBT and fluoxetine increased the mean of ISE scores more than control group after intervention [p<0.0001, p=0.033; respectively], but increase in the CBT group was significantly greater than flouxetine group. Finally, there was evidence of high infertility self-efficacy for women exposed to the intervention compared with those in the control group. Also, there was an improvement in depression. Both fluoxetine and CBT decreased significantly the mean of BDI scores more than the control group; decrease in the CBT group was significantly more than that in the fluoxetine group. CBT can serve as an effective psychosocial intervention for promoting self-efficacy of infertile women